The Oligonucleotide Therapeutics Society (OTS) is an open, nonprofit forum to foster research and development of oligonucleotide therapeutics.

The Founders’ vision was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities.

Oligonucleotide therapeutics are now being used to successfully treat diseases and have the potential for widespread application. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. Incredibly, oligonucleotide therapeutics have also been used to create an individualized treatment for one single person with a rare, fatal disease.

All the latest news

FEATURED ARTICLE

Fanzor: A Programmable RNA-Guided System In Eukaryotes Similar to CRISPR

FEATURED ARTICLE

RNAi: The Persistence of a Few Leads to Success

Featured Member

Leonora Abdullahu

Leonora Abdullahu, PhD

Genetic Medicines Search and Evaluation
Eli Lilly & Company

What’s special about the work I’m currently doing in External Innovation at Eli Lilly, is that it allows us to partner with biotech’s in the field that have assets aligned with Lilly’s strategic goals and internal discovery efforts, and provide them with the resources and expertise to bring those assets to the market. This really expedites the drug discovery process, allowing us to make leaps instead of steps!

  • BECOME A MEMBER

Membership is an opportunity to take advantage of an array of benefits that support the society’s mission to foster academia and industry-based research and development of oligonucleotide therapeutics, all at a reasonable rate!

  • AWARD & TRAVEL GRANTS

The Oligonucleotide Therapeutics Society offers the opportunity for both members and non-members to apply for various awards to support the accomplishments of students, postdocs and young investigators.

Webinars

featured

Upcoming Webinar

Matthew Stanton

Non-viral DNA delivery: Opportunities and challenges

8AM PST / 11AM EST / 5PM CET
Date: October 12, 2023
Speaker: Matthew Stanton
Matthew Stanton, PhD

Past Webinars

Job Board

If you are looking for great people in the field of oligonucleotide therapeutics, we encourage you to post your job openings on our job board. It’s free to post!  Just register as an employer and start posting your openings.

  • EMPLOYERS

The OTS Job Board allows you to, Post/Edit Jobs Review/Filter Resumes Manage Employer Profiles

  • JOB SEEKER

Search the latest job postings in the field of oligonucleotide therapeutics. The OTS Job Board allows you to: Search Jobs, Upload Resume, Create Job Alerts